Femara – Letrozol 2.5mg is a non-steroidal aromatase inhibitor that works by blocking the aromatase enzyme, responsible for converting androgens into estrogen. In clinical medicine, Femara is used in postmenopausal women with hormone-sensitive breast cancer. In performance enhancement contexts, it is used to manage or prevent estrogenic side effects such as water retention, gynecomastia, and fat gain, particularly during or after anabolic steroid cycles.
Femara is significantly stronger than other AIs like Arimidex, and it can reduce estrogen levels dramatically. This makes it especially effective in high-aromatizing cycles, but also increases the risk of excessive estrogen suppression if not dosed properly.
Benefits
Potent suppression of estrogen conversion
Prevents or reverses gynecomastia (estrogen-related breast tissue)
Reduces water retention and bloating
Improves muscle definition and hardness during cycles
Supports hormonal balance in post-cycle therapy when needed
Side effects
Joint pain or stiffness
Fatigue or weakness
Decreased libido
Mood swings or irritability
Headaches
Bone density reduction with prolonged overuse
Risk of over-suppression of estrogen leading to negative effects on cholesterol and immune system
Dosages & Protocol
Dosages for Men:
Typical on-cycle dose: 0.25mg to 0.5mg every other day to manage estrogen levels
High-estrogen cycles: Up to 1mg every other day if needed (monitor estrogen levels closely)
PCT or severe gynecomastia: 2.5mg per day for short durations (3–5 days), then taper down
Not recommended for women due to high chance of estrogen suppression and hormonal disruption.
How to administerTake Femara – Letrozol 2.5mg orally with water. It can be taken with or without food. Due to its long half-life and potency, spacing doses every other day or every third day is often sufficient. Regular bloodwork is advised to ensure estrogen levels remain within a healthy range and avoid over-suppression.
StorageStore Femara in a cool, dry place away from direct sunlight and moisture. Keep sealed and out of reach of children.
Half life & detectabilityHalf-Life: Approximately 2–4 days, allowing for every-other-day dosingDetection Time: Estimated up to 30–60 days depending on dosage and individual metabolismFor athletes subject to drug testing, it is crucial to consider these detection times to avoid positive tests for banned substances.

